市場調查報告書

組織學的檢驗與細胞學檢驗的全球市場:2019年-2025年

Histology and Cytology Market 2019-2025

出版商 Orion Market Research Pvt Ltd 商品編碼 949377
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
組織學的檢驗與細胞學檢驗的全球市場:2019年-2025年 Histology and Cytology Market 2019-2025
出版日期: 2020年05月12日內容資訊: 英文
簡介

全球組織學的檢驗與細胞學的檢驗的市場,預計到2025年踏實成長。市場擴大的原動力,是感染疾病和癌症的盛行率上升和免疫組織化學的進步等要素。全球癌症患者數,2018年的時達到4,380萬人,組織學檢驗工具和細胞學的檢驗工具主要用於癌症的診斷,預計隨著患者數的增加也擴大需求。

本報告提供全球組織學的檢驗與細胞學的檢驗的市場調查,市場概要,競爭情形,決定市場方向性決策的要素,各類型,各產品,各終端用戶,各地區的分析,企業簡介等資訊。

目錄

第1章 報告概要

第2章 市場概要與考察

  • 調查範圍
  • 分析師的考察與市場的最新趨勢
  • 法律規章

第3章 競爭情形

  • 公司佔有率分析
  • 主要策略分析
  • 主要企業分析
    • Abbott Laboratories
    • Merck KGaA
    • F. Hoffmann-La Roche AG
    • Hologic,Inc.
    • Becton, Dickinson and Co.

第4章 市場決策要素

  • 成長促進因素
  • 成長阻礙因素
  • 市場機會

第5章 市場區隔

  • 各類型市場
    • 組織學檢驗
    • 細胞學檢驗
  • 各產品市場
    • 試劑與消耗品
    • 設備和析軟體系統
  • 各終端用戶市場
    • 醫院與臨床檢驗室
    • 學術研究機關

第6章 地區分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 其他
  • 其他地區

第7章 企業簡介

  • Abbott Laboratories
  • Becton, Dickinson and Co.
  • CBG Biotech
  • CONMED Corp.
  • Danaher Corp.
  • Diapath S.p.A.
  • Epredia
  • F. Hoffmann-La Roche AG
  • Guangzhou Hongqi Optical Instrument Technology Co., Ltd.
  • Hologic, Inc.
  • ILSA Diagnostic
  • Koninklijke Philips N.V.
  • Leica Biosystems Nussloch GmbH
  • Medimeas
  • Merck KGaA
  • PerkinElmer, Inc.
  • Primera Technology, Inc.
  • Radical Scientific Equipments Pvt. Ltd.
  • Sysmex Corp.
  • Trivitron Healthcare
目錄
Product Code: OMR2021695

Global Histology and Cytology Market Size, Share & Trends Analysis Report, By Type of Examination (Histology and Cytology), By Product (Reagents and Consumables, and Instruments and Analysis Software System), By End-User (Hospitals and Clinical Laboratories and Academic and Research Institutes) and Forecast, 2019-2025

The global histology and cytology market is estimated to witness significant growth during the forecast period. The major factors contributing to the growth of the market include the increasing prevalence of infectious diseases and cancer and rising advances in immunohistochemistry. Globally, 43.8 million patients were suffering from cancer in 2018. This leads to the demand for histology and cytology tools as they are mainly used for the diagnosis of cancer. In breast cancer, this is used for routine immunohistochemistry (IHC) evaluation of hormone receptors (oestrogen and progesterone receptors) as well as evaluation of Ki67 (a marker of tumour proliferation) and HER2 expression. Such factors strongly influence prognosis and opt for the appropriate anti-cancer treatments. Molecular histopathology with the use of in-situ hybridization (ISH) techniques also offers additional information that supports prognosis and treatment of breast cancer and other cancers.

Geographically, the global histology and cytology market is segmented based on four major regions, including North America, Europe, Asia-Pacific, and Rest of the World (RoW). In 2018, North America is anticipated to hold the largest share in the market owing to the presence of some crucial players, including Abbott Laboratories, Hologic, Inc., and Becton, Dickinson, and Co. in the region. Additionally, there is a significant awareness regarding chronic diseases in the region, which leads to the early diagnosis of the condition and better survival rate in the country. This contributes to the demand for histology and cytology instruments to diagnose chronic conditions, including cancer and diabetes.

Key players in the market include Abbott Laboratories, Merck KGaA, F. Hoffman-La Roche AG, Hologic, Inc., and Becton, Dickinson, and Co. Mergers and acquisitions, product launches, and partnerships and collaborations are some crucial strategies adopted by the market players to expand market share and gain a competitive advantage. For instance, In June 2019, PHC Holdings Corp. acquired Anatomical Pathology business from Thermo Fisher Scientific Inc., for nearly $1.1 billion. Anatomical Pathology business of Thermo Fisher Scientific is a part of Specialty Diagnostics division. With the acquisition of Thermo Fisher's Anatomical Pathology business, a new stand-alone company named Epredia was established to serve comprehensive anatomical pathology solutions.

Research Methodology

The market study of the global histology and cytologymarket is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings authenticity in our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market
  • Authentic public databases
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog

The report provides in-depth analysis on market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation:

  • Global Histology and CytologyMarket Research and Analysis, By Type of Examination
  • Global Histology and CytologyMarket Research and Analysis, By Product
  • Global Histology and CytologyMarket Research and Analysis, By End-User

The Report Covers:

  • Comprehensive research methodology of the globalhistology and cytologymarket.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global histology and cytologymarket.
  • Insights about market determinants which are stimulating the global histology and cytologymarket.
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography
    • 1.2.3. By Stakeholders

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Company Share Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. Abbott Laboratories
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. SWOT Analysis
      • 3.3.1.4. Recent Developments
    • 3.3.2. Merck KGaA
      • 3.3.2.1. Overview
      • 3.3.2.2. Financial Analysis
      • 3.3.2.3. SWOT Analysis
      • 3.3.2.4. Recent Developments
    • 3.3.3. F. Hoffmann-La Roche AG
      • 3.3.3.1. Overview
      • 3.3.3.2. Financial Analysis
      • 3.3.3.3. SWOT Analysis
      • 3.3.3.4. Recent Developments
    • 3.3.4. Hologic, Inc.
      • 3.3.4.1. Overview
      • 3.3.4.2. Financial Analysis
      • 3.3.4.3. SWOT Analysis
      • 3.3.4.4. Recent Developments
    • 3.3.5. Becton, Dickinson and Co.
      • 3.3.5.1. Overview
      • 3.3.5.2. Financial Analysis
      • 3.3.5.3. SWOT Analysis
      • 3.3.5.4. Recent Developments

4. Market Determinants

  • 4.1 Motivators
  • 4.2 Restraints
  • 4.3 Opportunities

5. Market Segmentation

  • 5.1. Global Histology and Cytology Market by Type of Examination
    • 5.1.1. Histology
    • 5.1.2. Cytology
  • 5.2. Global Histology and Cytology Market by Product
    • 5.2.1. Reagents and Consumables
    • 5.2.2. Instruments and Analysis Software System
  • 5.3. Global Histology and Cytology Market by End-User
    • 5.3.1. Hospitalsand Clinical Laboratories
    • 5.3.2. Academic and Research Institutes

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Abbott Laboratories
  • 7.2. Becton, Dickinson and Co.
  • 7.3. CBG Biotech
  • 7.4. CONMED Corp.
  • 7.5. Danaher Corp.
  • 7.6. Diapath S.p.A.
  • 7.7. Epredia
  • 7.8. F. Hoffmann-La Roche AG
  • 7.9. Guangzhou Hongqi Optical Instrument Technology Co., Ltd.
  • 7.10. Hologic, Inc.
  • 7.11. ILSA Diagnostic
  • 7.12. Koninklijke Philips N.V.
  • 7.13. Leica Biosystems Nussloch GmbH
  • 7.14. Medimeas
  • 7.15. Merck KGaA
  • 7.16. PerkinElmer, Inc.
  • 7.17. Primera Technology, Inc.
  • 7.18. Radical Scientific Equipments Pvt. Ltd.
  • 7.19. Sysmex Corp.
  • 7.20. Trivitron Healthcare

LIST OF TABLES

  • 1. GLOBAL HISTOLOGY AND CYTOLOGY MARKET RESEARCH AND ANALYSIS BY TYPE OF EXAMINATION, 2018-2025 ($ MILLION)
  • 2. GLOBAL HISTOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 3. GLOBAL CYTOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 4. GLOBAL HISTOLOGY AND CYTOLOGY MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2018-2025 ($ MILLION)
  • 5. GLOBAL HISTOLOGY AND CYTOLOGYREAGENTS AND CONSUMABLES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 6. GLOBAL HISTOLOGY AND CYTOLOGYINSTRUMENTS AND ANALYSIS SOFTWARE SYSTEM MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 7. GLOBAL HISTOLOGY AND CYTOLOGY MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
  • 8. GLOBAL HISTOLOGY AND CYTOLOGY IN HOSPITALS AND CLINICAL LABORATORIES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 9. GLOBAL HISTOLOGY AND CYTOLOGY IN ACADEMIC AND RESEARCH INSTITUTES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 10. GLOBAL HISTOLOGY AND CYTOLOGY MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)
  • 11. NORTH AMERICAN HISTOLOGY AND CYTOLOGY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 12. NORTH AMERICAN HISTOLOGY AND CYTOLOGY MARKET RESEARCH AND ANALYSIS BY TYPE OF EXAMINATION, 2018-2025 ($ MILLION)
  • 13. NORTH AMERICAN HISTOLOGY AND CYTOLOGY MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2018-2025 ($ MILLION)
  • 14. NORTH AMERICAN HISTOLOGY AND CYTOLOGY MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
  • 15. EUROPEAN HISTOLOGY AND CYTOLOGY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 16. EUROPEAN HISTOLOGY AND CYTOLOGY MARKET RESEARCH AND ANALYSIS BY TYPE OF EXAMINATION, 2018-2025 ($ MILLION)
  • 17. EUROPEAN HISTOLOGY AND CYTOLOGY MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2018-2025 ($ MILLION)
  • 18. EUROPEAN HISTOLOGY AND CYTOLOGY MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
  • 19. ASIA-PACIFIC HISTOLOGY AND CYTOLOGY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 20. ASIA-PACIFIC HISTOLOGY AND CYTOLOGY MARKET RESEARCH AND ANALYSIS BY TYPE OF EXAMINATION, 2018-2025 ($ MILLION)
  • 21. ASIA-PACIFIC HISTOLOGY AND CYTOLOGY MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2018-2025 ($ MILLION)
  • 22. ASIA-PACIFIC HISTOLOGY AND CYTOLOGY MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
  • 23. REST OF THE WORLD HISTOLOGY AND CYTOLOGY MARKET RESEARCH AND ANALYSIS BY TYPE OF EXAMINATION 2018-2025 ($ MILLION)
  • 24. REST OF THE WORLD HISTOLOGY AND CYTOLOGY MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2018-2025 ($ MILLION)
  • 25. REST OF THE WORLD HISTOLOGY AND CYTOLOGY MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL HISTOLOGY AND CYTOLOGY MARKET SHARE BY TYPE OF EXAMINATION, 2018 VS 2025 (%)
  • 2. GLOBAL HISTOLOGY AND CYTOLOGY MARKET SHARE BY PRODUCT, 2018 VS 2025 (%)
  • 3. GLOBAL HISTOLOGY AND CYTOLOGY MARKET SHARE BY END-USER, 2018 VS 2025 (%)
  • 4. GLOBAL HISTOLOGY AND CYTOLOGY MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)
  • 5. US HISTOLOGY AND CYTOLOGY MARKET SIZE, 2018-2025 ($ MILLION)
  • 6. CANADA HISTOLOGY AND CYTOLOGY MARKET SIZE, 2018-2025 ($ MILLION)
  • 7. UK HISTOLOGY AND CYTOLOGY MARKET SIZE, 2018-2025 ($ MILLION)
  • 8. FRANCE HISTOLOGY AND CYTOLOGY MARKET SIZE, 2018-2025 ($ MILLION)
  • 9. GERMANY HISTOLOGY AND CYTOLOGYMARKET SIZE, 2018-2025 ($ MILLION)
  • 10. ITALY HISTOLOGY AND CYTOLOGY MARKET SIZE, 2018-2025 ($ MILLION)
  • 11. SPAIN HISTOLOGY AND CYTOLOGY MARKET SIZE, 2018-2025 ($ MILLION)
  • 12. ROE HISTOLOGY AND CYTOLOGY MARKET SIZE, 2018-2025 ($ MILLION)
  • 13. INDIA HISTOLOGY AND CYTOLOGY MARKET SIZE, 2018-2025 ($ MILLION)
  • 14. CHINA HISTOLOGY AND CYTOLOGY MARKET SIZE, 2018-2025 ($ MILLION)
  • 15. JAPAN HISTOLOGY AND CYTOLOGY MARKET SIZE, 2018-2025 ($ MILLION)
  • 16. REST OF ASIA-PACIFIC HISTOLOGY AND CYTOLOGY MARKET SIZE, 2018-2025 ($ MILLION)
  • 17. REST OF THE WORLD HISTOLOGY AND CYTOLOGY MARKET SIZE, 2018-2025 ($ MILLION)